Asimov
Founded Year
2017Stage
Series B | AliveTotal Raised
$204.7MLast Raised
$175M | 3 yrs agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-37 points in the past 30 days
About Asimov
Asimov focuses on the design of living systems within the biotechnology sector. The company provides cells, genes, and software for genetic design, facilitating the production of biologics and gene therapies. Asimov's platform is used for the design, simulation, and optimization of genetic systems in different cell types. It was founded in 2017 and is based in Boston, Massachusetts.
Loading...
Loading...
Expert Collections containing Asimov
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Asimov is included in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
238 items
Companies involved in design and development of new biological parts, devices, and systems; as well as the re-design of existing biological systems.
Asimov Patents
Asimov has filed 7 patents.
The 3 most popular patent topics include:
- molecular biology
- biotechnology
- gene delivery
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/2/2019 | Clusters of differentiation, Immune system, Immunology, Transcription factors, T cells | Application |
Application Date | 8/2/2019 |
|---|---|
Grant Date | |
Title | |
Related Topics | Clusters of differentiation, Immune system, Immunology, Transcription factors, T cells |
Status | Application |
Latest Asimov News
Oct 6, 2025
By stably integrating all essential viral genes into the genome of HEK293 cells, Asimov generates high-titer, clonal producer cell lines. Stable clones eliminate the need for costly GMP plasmids. The post Asimov Launches Stable AAV Producer Cell Lines for Viral Vector Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News.
Asimov Frequently Asked Questions (FAQ)
When was Asimov founded?
Asimov was founded in 2017.
Where is Asimov's headquarters?
Asimov's headquarters is located at 201 Brookline Avenue, Boston.
What is Asimov's latest funding round?
Asimov's latest funding round is Series B.
How much did Asimov raise?
Asimov raised a total of $204.7M.
Who are the investors of Asimov?
Investors of Asimov include Pillar, Andreessen Horowitz, Horizons Ventures, CPP Investments, KdT Ventures and 11 more.
Who are Asimov's competitors?
Competitors of Asimov include Ginkgo Bioworks.
Loading...
Compare Asimov to Competitors
Evolva is a biotechnology company focused on researching, developing, and commercializing nature-based ingredients for various sectors including flavors and fragrances, and health ingredients. The company offers ingredients that are derived from natural sources and are available in any quantity. Evolva primarily serves the flavors and fragrances industry, as well as sectors requiring health and wellness ingredients. It was founded in 2004 and is based in Reinach, Switzerland.
bitBiome is a biotechnology company focused on discovering and engineering enzymes, as well as sequencing microbiomes. The company provides services including enzyme discovery, modification, and analysis of microbiome data. bitBiome employs its platforms to support research and development from enzyme discovery to application. It was founded in 2018 and is based in Tokyo, Japan.
Scala Biodesign specializes in computational protein design within the biotechnology sector. The company provides computational solutions aimed at improving the stability and activity of proteins, relevant for their use in commercial products. Scala's technology is utilized in several industries, including pharmaceuticals, chemicals, and sustainability. It was founded in 2022 and is based in Tel-Aviv, Israel.
Adaptyv Biosystems operates within the biotechnology sector and focuses on Artificial Intelligence (AI) driven protein design. The company provides laboratory services for synthesizing and testing proteins, using generative AI for protein design and experimental data for protein functionality characterization. Adaptyv serves the biotechnology and pharmaceutical industries with its cloud-based lab platform for protein designers. It was founded in 2020 and is based in Epalinges, Switzerland.
Abolis is a biotechnology company. The company develops solutions utilizing microorganisms to produce alternatives to petrochemical and plant-based products. Abolis serves industries aiming to improve their sustainability practices through biotechnological methods. It was founded in 2014 and is based in Evry, France.
Molecular You provides preventive health assessments and lifestyle coaching within the health sector. The company offers a health report based on blood profile analysis, detailing an individual's current health status and future disease risks. It serves individuals seeking personalized health care and organizations interested in population health management. It was founded in 2014 and is based in Vancouver, Canada.
Loading...